SCHEMBL5261050

SCHEMBL5261050

COc1cc2nc(-c3ccc(C(F)(F)F)cc3)nc(Cl)c2cc1OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ WHR1 P49842 1/20 0.49
▸ ABCG2 Q9UNQ0 3/20 0.43
▸ NPSR1 Q6W5P4 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ STAT6 P42226 1/20 0.43
▸ PDE3B Q13370 1/20 0.42
▸ PDE3A Q14432 1/20 0.42
▸ IDO1 P14902 1/20 0.42
▸ TDO2 P48775 1/20 0.42
▸ SLC2A1 P11166 1/20 0.41
▸ ADRA1D P25100 1/20 0.41
▸ ADRA1A P35348 1/20 0.41
▸ ADRA1B P35368 1/20 0.41
▸ KDR P35968 3/20 0.40
▸ EGFR P00533 1/20 0.40
▸ ERBB2 P04626 1/20 0.40
▸ EPHA2 P29317 1/20 0.40
▸ EPHB4 P54760 1/20 0.40
▸ NTSR1 P30989 1/20 0.40
▸ KRAS P01116 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24393307 0.85 WHR1 (0.50) WHR1ABCG2NPSR1KDM4ESTAT6
SCHEMBL10063506 0.85 WHR1 (0.52) WHR1ABCG2NPSR1KDM4ESTAT6
SCHEMBL5258591 0.85 WHR1 (0.55) WHR1NPSR1KDM4ESTAT6SLC2A1
SCHEMBL5257441 0.84 WHR1 (0.49) WHR1ABCG2NPSR1KDM4ESTAT6
SCHEMBL29589358 0.83 WHR1 (0.54) WHR1ABCG2NPSR1KDM4ESTAT6
SCHEMBL3469022 0.83 WHR1 (0.54) WHR1ABCG2NPSR1KDM4ESTAT6
SCHEMBL5262953 0.83 WHR1 (0.54) WHR1NPSR1KDM4ESTAT6PDE3B
SCHEMBL3976324 0.82 SLC2A1 (0.56) WHR1ABCG2NPSR1KDM4ESTAT6
SCHEMBL16384708 0.82 WHR1 (0.52) WHR1NPSR1KDM4ESTAT6SLC2A1
SCHEMBL24391550 0.82 WHR1 (0.47) WHR1ABCG2NPSR1KDM4ESTAT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1040101-B1 SUBSTITUTED 2-ARYL-4-AMINO-CHINAZOLINES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS SANOFI AVENTIS DEUTSCHLAND (DE) 2007-04-25 — — EP disclosed
US-6613772-B1 Drugs such as 2-(p-chlorophenyl-4-(4-hydroxybutyl)amino-6,7,8 -trimethoxyquinazoline used for activation of guanylate cyclase and modulation of cyclic guanosine monophosphate AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-09-02 — — US disclosed
EP-1040101-A1 SUBSTITUTED 2-ARYL-4-AMINO-CHINAZOLINES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS Aventis Pharma Deutschland GmbH (DE) 2000-10-04 — — EP disclosed
WO-1999032460-A1 SUBSTITUTED 2-ARYL-4-AMINO-CHINAZOLINES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 1999-07-01 — — WO disclosed
Send feedback